Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-007972-70-BE
EUCTR2008-007972-70-BE
Active, not recruiting
Phase 1

Transplacentar pharmacokinetics of remifentanil

niversity Hospital Leuven0 sites50 target enrollmentDecember 11, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTransplacentar pharmacokinetics of Remifentanil
DrugsUltiva

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Transplacentar pharmacokinetics of Remifentanil
Sponsor
niversity Hospital Leuven
Enrollment
50
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 11, 2008
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
niversity Hospital Leuven

Eligibility Criteria

Inclusion Criteria

  • •Pregnant females who are scheduled for a selective foeticide because of non viabel fetal disorder or intra\-uterine fetal blood transfusion
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Maternal contra indication for the use of remifentanil or severe fetal asphyxia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
The effect of intravenous infusion of remifentanil and dexmedetomidine on hemodynamic changes and pain in patients undergoing cataract surgery
IRCT20220302054164N2Arak University of Medical Sciences122
Active, not recruiting
Not Applicable
Remifentanil in childre
EUCTR2015-000051-24-FIKlaus Olkkola/University of Helsinki
Completed
Not Applicable
Pharmacodynamic interactions between remifentanil and dexmedetomidine (PIRAD)
NL-OMON45644niversitair Medisch Centrum Groningen30
Active, not recruiting
Phase 1
PD interaction of DMED and REMIWe will include 30 healthy volunteers (American Society ofAnesthesiologists 1) stratified to age groups to differentsequence of anesthesia regimenTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Equipment and Supplies [E07]
EUCTR2017-000945-37-NLMCG30
Completed
Not Applicable
Maternal and neonatal effects of remifentanil in general anaesthesia for Caesarean deliveryRemifentanil.Opioids and related analgesics
IRCT201102252963N2Shahid Sadoughi University of Medical Sciences80